Botulinum Toxic-Coated Microneedles Market Size, Share, Opportunities, And Trends By Type (Solid Microneedles, Coated Microneedles, Hollow Microneedles, Dissolvable Microneedles), By Material (Silicon, Metals, Glass, Others), By Application (Hyperhidrosis, Crow's Feet), By End-User (Hospital, Beauty Salon), And By Geography - Forecasts From 2024 To 2029

The botulinum toxic coated microneedles market is anticipated to show steady growth during the forecast period.

Botulinum toxin-coated microneedles are a novel approach to drug delivery that has garnered considerable attention recently. These microneedles offer a less intrusive alternative to traditional injections for cosmetic procedures such as wrinkle reduction and facial rejuvenation. Botulinum toxin-infused microneedles have the potential to revolutionize the treatment of wrinkles and hyperhidrosis (excessive sweating). By administering the toxin directly to specific areas, these minuscule needles provide a potentially painless and highly regulated alternative to traditional injections. Increased demand for non–invasive surgery, increased elderly population, and rise in demand for cosmetics procedures are driving the botulinum toxic coated microneedles market growth.

Market Drivers

• Increased demand for non–invasive surgery enhances botulinum toxic coated microneedles market growth.

The increasing popularity of non-surgical facial treatments such as fillers and pre-juvenation procedures is paving the way for the rise of botulinum toxin microneedles. These minimally invasive solutions cater to the same demographic looking to diminish wrinkles, positioning them as a logical progression and driving expansion in the market. The American Academy of Facil Plastic and Reconstructive Surgery (AAFPRS) has unveiled the findings of its yearly member survey, providing insights into the latest trends in facial plastic surgery. The demand for facelifts has been steadily growing, as evidenced by the rising popularity of this cosmetic procedure. In the year 2023, the surgeons of the AAFPRS conducted an average of 48 facelifts or partial facelifts, indicating a notable increase in the number of individuals opting for this rejuvenating treatment.

• Increased elderly population drives botulinum toxic coated microneedles market growth.

An increasing number of elderly individuals leads to a rise in the need for wrinkle reduction solutions. Botulinum toxin-coated microneedles represent a hopeful advancement in this field. These minimally invasive needles administer the toxin for wrinkle reduction, offering the potential for reduced side effects and a more organic appearance in contrast to conventional injections. According to the United Nations published article in “World Social Report 2023”, the global population of individuals aged 65 years or above is estimated to undergo a significant increase, surpassing 761 million in 2021 and reaching 1.6 billion by 2050. Moreover, the growth rate of individuals aged 80 years or above is even more rapid. In 2021, the proportion of individuals aged 65 or above worldwide stood at 1 in 10. However, projections indicate that by 2050, this age group is expected to make up 1 in 6 of the global population.

• Rise in demand for cosmetics procedure boosts botulinum toxic coated microneedles market growth.

Minimally invasive techniques are becoming increasingly popular. An excellent illustration of this is the use of microneedles coated with botulinum toxin. These microneedles provide a more subtle and non-invasive method for delivering wrinkle-relaxing toxin, offering a convenient and natural-looking approach to facial rejuvenation. According to Aesthetic Society Published article in 2022, there was a notable rise of 14% in the overall number of aesthetic procedures performed. The increased number can be attributed to the significant surge of 23% in nonsurgical procedures. It is interesting to note that surgical procedures only accounted for 20% of all aesthetic procedures, which contributed to 70% of the total revenue. The American Society of Plastic Surgeons (ASPS) published an article in September 2023, which represents 92 percent of all board-certified plastic surgeons in the United States, and has unveiled the findings of the 2022 procedural research. The results were released in collaboration with partners Cosmetassure and Patient Now. The information indicated that a combined total of 26.2 million surgical and minimally invasive cosmetic and reconstructive surgeries were performed in the United States in 2022.

North America is projected to grow gradually.

North America is projected to account for a significant share of the botulinum toxic-coated microneedles market due to the rise in sales of the beauty industry. The increasing trend of opting for non-invasive cosmetic treatments in order to attain a more youthful look drives the need for Botulinum Toxic-microneedles. According to Circana, in January 2024, a prominent authority on consumer behavior, the dollar sales in the U.S. prestige beauty industry witnessed a remarkable growth of 14% in 2023, reaching a staggering $31.7 billion. In contrast, the mass market beauty sector observed a comparatively modest year-over-year increase of 6% in dollar sales. According to Circana, in November 2023, formerly known as IRI, the Canadian beauty market experienced a significant increase in sales revenue of 18% during the nine-month period ending in September compared to the previous year. The growth was observed across all categories, including makeup, skincare, fragrance, and hair, with each category showing double-digit growth. As a result, the industry can be considered to be in a favorable and prosperous state.

Market Restraints

• Dosage and Accuracy Issues impact botulinum toxic coated microneedles market growth.

Administering an accurate and uniform amount of botulinum toxin via microneedles can pose a challenge. While injections focus on particular muscles, microneedles may produce a more widespread impact, necessitating additional investigation into the most effective dosing techniques.

• Extensive clinal trails curb botulinum toxic coated microneedles market growth.

Extensive clinical trials are imperative to establish the safety and effectiveness of microneedles containing botulinum toxin for each unique intended use. This undertaking can be both time-consuming and costly.

Key Developments

• January 2023: Galderma disclosed encouraging top-line findings from the phase III READY-3 clinical study, which evaluated the efficacy of RelabotulinumtoxinA in treating glabellar lines (frown lines) and lateral canthal lines (crow's feet). The trial examined the effectiveness of the treatment when targeting each area individually.
• February 2022: Healis Therapeutics, a privately owned biotechnology firm, revealed that it has acquired a significant botulinum toxin patent from AbbVie.

Company Products

• BOTOX® Cosmetic (onabotulinumtoxinA): offered by AbbVie, is a prescribed drug that is administered through injections into the muscles. Its purpose is to provide temporary enhancement to the appearance of adults by reducing the visibility of moderate to severe frown lines, crow's feet lines, and forehead lines.

Segmentation

• By Type
  • Solid Microneedles
  • Coated Microneedles
  • Hollow Microneedles
  • Dissolvable Microneedles
• By Material
  • Silicon
  • Metals
  • Glass
  • Others
• By Application
  • Hyperhidrosis
  • Crow's Feet
• By End-User
  • Hospital
  • Beauty Salon
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others